Wearable temperature sensor provides early warning for complications in cancer patients

The device, which takes measurements every two minutes, was able to detect infection and cytokine release syndrome events several hours sooner than routine monitoring.

11:54 AM

Author | Ian Demsky

red thermometer background in white
Getty Images

A simple, wearable temperature sensor was able to detect dangerous complications in hospitalized cancer patients hours earlier than routine monitoring, a team from the University of Michigan Rogel Cancer Center found.

The device, which takes readings every two minutes and wirelessly transmits them to the cloud, was able to quickly detect adverse events that affect body temperature, like infection and cytokine release syndrome, allowing for swifter interventions, according to findings published in Cancer Cell.

The study examined data from 62 patients at the U-M who were undergoing treatment that included a hematopoietic stem cell transplant or CAR-T therapy using a wearable sensor already approved by the Food and Drug Administration for home use.

The researchers were able to detect potentially dangerous fevers about five hours earlier than standard temperature checks, which typically happen every 4-8 hours in the hospital.

Along with frequent monitoring of fluctuations in each patient's temperature, the study also examined more subtle changes in temperature that may appear as deviations from the patient's baseline circadian pattern, signaling a potential problem before a steep temperature rise.

"This lead time is clinically significant for patients with cancer, who are commonly immunocompromised and at risk for infection," said study co-senior author Muneesh Tewari, Ph.D., a professor of internal medicine and of biomedical engineering at U-M. "How quickly doctors can administer antibiotics can play an important role in combatting potentially fatal infections and sepsis."

The monitoring approach could also facilitate moving some costly inpatient CAR-T care to the outpatient setting by providing additional lead time for the patient to return if a problem was detected, noted the study's other senior author
Sung Won Choi, M.D., an associate professor of pediatric hematology and oncology.

The research builds on previous studies in mice.

Disclosure: Six of the study authors are inventors of intellectual property related to the work, for which the University of Michigan is pursuing intellectual property protections.

Paper cited: "High-frequency temperature monitoring for early detection of febrile adverse events in patients with cancer," Cancer Cell. DOI: 10.1016/j.ccell.2021.07.019

More Articles About: Lab Notes Cancer Research Cancer: Cancer Types All Research Topics Cancer: Help, Diagnosis & Treatment
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]


Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Featured News & Stories hospital bed
Health Lab
Even at top hospitals, low-income older cancer patients struggle after surgery
Unequal outcomes, and higher spending, seen in patients over 65 who are “dual eligible” for Medicare and Medicaid.
pills floating blue pink dark background physician in middle looking at chart white coat scrubs
Health Lab
Better medical record-keeping needed to fight antibiotic overuse, studies suggest
Efforts to reduce overuse of antibiotics may be hampered by incomplete medical records that don’t show the full reasons for prescriptions.
zoom screens with 7 different backgrounds and doctor silhouettes outlined in each
Health Lab
The doctor is in…. but what’s behind them?
A study reveals that what a doctor has behind them during a telehealth visit can make a difference in how the patient feels about them and their care.
surgery gloves passing tool blue and yellow
Health Lab
A universal heparin reversal drug is shown effective in mice
The newest version of the heparin reversal drug, described in a recent issue of Advanced Healthcare Materials, adjusted the number of protons bound to it, making the molecule less positive so it would preferentially bind to the highly negative heparin, resulting in a much safer drug.
blue gloves in hospital hanging IV bag
Health Lab
Commonly used antibiotic brings more complications, death in the sickest patients
In emergency rooms and intensive care units across the country, clinicians make split-second decisions about which antibiotics to give a patient when a life threatening infection is suspected. Now, a study reveals that these decisions may have unintended consequences for patient outcomes.
mushrooms in a microscope
Health Lab
How cannabis and psilocybin might help some of the 50 million Americans experiencing chronic pain
Recent developments represent a dramatic change from long standing federal policy around these substances that has historically criminalized their use and blocked or delayed research efforts into their therapeutic potential.